Table 2.
- Epidemiological, laboratory and clinical characteristics of chronic HDV carriers with detectable and undetectable HDV-RNA.
| Variable | HDV |
OR (CI 95 %) | p valuea | |
|---|---|---|---|---|
| RNA-HDV undetectable |
RNA-HDV detectable |
|||
| n = 21 (%) | n = 29 (%) | |||
| Age group | ||||
| ≤40 | 1 (4.8) | 5 (17.2) | 1 | |
| 41-50 | 7 (33.3) | 12 (41.4) | 0.342 (0.016–2.743) | 0.370 |
| 51-60 | 8 (38.1) | 8 (27.6) | 0.200 (0.009–1.624) | 0.181 |
| ≥60 | 5 (23.8) | 4 (13.8) | 0.160 (0.006–1.562) | 0.153 |
| Sex | ||||
| Female | 11 (52.4) | 12 (41.4) | 1.544 (0.435–5.598) | 0.567 |
| Male | 10 (47.6) | 17 (58.6) | ||
| Fibrosis stage | ||||
| F0/F1 | 9 (42.9) | 9 (31) | 1 | |
| F2/F3 | 4 (19) | 8 (27.6) | 2 (0.439–9.096) | 0.369 |
| F4 | 8 (38.1) | 12 (41.4) | 1.499 (0.414–5.427) | 0.536 |
a
Fisher's exact test.